This site is intended for health professionals only
Module Summary

Managing grossly abnormal LFTs, during the Covid-19 pandemic when there is minimal secondary care help available

Learning Objectives

This article will update you on actions to take in the case of:

  • A presentation of jaundice 
  • Markedly deranged liver enzymes in the absence of jaundice 
  • More minor elevations of liver enzymes
Author

Professor Stephen Ryder is Consultant Hepatologist at Nottingham University Hospitals NHS Trust and Honorary Professor University of Nottingham, School of Medicine. Professor Ryder is Chair of the Hepatitis C Coalition

Date module published

Apr 24, 2020

Log in to access the full CPD module and track your progress toward certification.

Already registered?

Login here